Is CAH Becoming the Backbone of US Healthcare Infrastructure?
Cardinal Health is expanding beyond drug distribution into specialty care, logistics and nuclear medicine, deepening its role in US healthcare infrastructure.
More News
Bloomberg Businessweek Daily 5/18/2026
Today, Matt Schettenhelm, Bloomberg Intelligence Senior Litigation Analyst, breaks down a California's jury's rejection of Elon Musk's claim that Sam Altman betrayed OpenAI's original mission when it...
LifeMD (NASDAQ:LFMD - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.20) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.06). LifeMD had a negative return on equity of 83.93% and a net margin of 6.58%.The business had...
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates
LifeMD (LFMD) delivered earnings and revenue surprises of -42.86% and +3.97%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
LifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Moderate Buy" from Analysts
LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has been given an average rating of 'Moderate Buy' by the nine brokerages that are covering the firm, MarketBeat reports. One analyst has rated the stock...
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care
HIMS broadens its DTC platform with GLP-1 access, a new Benefits hub and global expansion to broaden convenient, personalized care.
LifeMD's (LFMD) Buy Rating Reiterated at BTIG Research
BTIG Research restated a "buy" rating and issued a $10.00 price objective on shares of LifeMD in a report on Monday...
LifeMD (LFMD) Projected to Post Quarterly Earnings on Tuesday
LifeMD (NASDAQ:LFMD) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...
Meta, Microsoft to Trim Workforces Amid AI Spending Bloomberg Businessweek Daily 4/23/2026
On today's episode of Bloomberg Businessweek Daily, Carol Massar and Tim Stenovec speak with Bloomberg Tech Co-Host Ed Ludlow about Meta and Microsoft looking to trim their workforces amid heavy AI...
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?
LifeMD (LFMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.